Melacine, the first therapeutic tumour vaccine for metastatic melanoma

March 2001

Schering is now marketing Melacine, the first therapeutic tumour vaccine for metastatic melanoma.

Melacine will be useful. The incidence of this lethal form of skin cancer is rising faster than any other cancer.

The vaccine consists of broken melanoma cells...and immune system stimulants that help create antibodies for the cancer cells.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

infections might play a significant role in many chronic diseases
Supplements glucosamine supplements might slow the progression of osteoarthritis
Supplements new concerns about the safety of kava
Hematology & Oncology Melacine, the first therapeutic tumour vaccine for metastatic melanoma
Women's Health Preven Emergency Contraceptive Kit is being discontinued
Women's Health new guidelines for using oral contraceptives in women with chronic conditions
Women's Health NSAIDs during pregnancy
Infectious Diseases Lyme vaccine triggers severe arthritis in some patients
Alertec for depression
Hepatitis C Trental (pentoxifylline) is beneficial for patients with severe alcoholic hepatitis
garlic supplements can decrease levels of the HIV protease inhibitor saquinavir (Fortovase, Invirase)
new thinking on when to start HIV therapy
acetylcysteine (Mucomyst, Parvolex) can help prevent renal damage
Vaccines misconceptions about immunizations
efforts to ease the pharmacist shortage